Name
Alexion, AstraZeneca Rare Disease
Company Description
Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 c
Product Categories (5)
Pharmaceuticals
Address
121 Seaport Blvd
Boston, MA 02210
United States